Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rethinking On-Target Off-Tumor Toxicity as a Hematopoietic Continuum.

European journal of haematology·2026
Same author

Mechanisms of post-transplant AML relapse and therapeutic implications.

Bone marrow transplantation·2026
Same author

Bridging Randomized Trial Efficacy and Real-World Effectiveness in Multiple Myeloma: Integrating Clinical Trials and Real-World Evidence for Individualized Care.

European journal of haematology·2026
Same author

Multiple Myeloma and the Illusion of the Evidence Pyramid.

European journal of haematology·2026
Same author

When MRD Is Not MRD: A Context-Dependent Interpretation in Clinical Decision-Making.

European journal of haematology·2026
Same author

Extranodal Marginal Zone Lymphoma: Integrating Etiology, Microenvironment, and Genetics Into Clinical Decision-Making.

European journal of haematology·2026

Related Experiment Video

Updated: Jul 14, 2026

Revealing the Ferroptotic Phenotype of Medulloblastoma
04:01

Revealing the Ferroptotic Phenotype of Medulloblastoma

Published on: March 15, 2024

Ferroptosis in Lymphoproliferative Disorders.

Santino Caserta1, Enrica Antonia Martino1, Ernesto Vigna1

  • 1Hematology Unit, Department of Onco-Hematology, Azienda Ospedaliera of Cosenza, 87100 Cosenza, Italy.

Cells
|July 13, 2026
PubMed
Summary

Ferroptosis, a cell death form driven by iron, is crucial in lymphoproliferative disorders. Targeting ferroptosis offers new treatments for resistant cancers.

Keywords:
cancer biologyferroptosislymphomalymphoproliferative disorders

Related Experiment Videos

Last Updated: Jul 14, 2026

Revealing the Ferroptotic Phenotype of Medulloblastoma
04:01

Revealing the Ferroptotic Phenotype of Medulloblastoma

Published on: March 15, 2024

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Ferroptosis is iron-dependent cell death, distinct from other regulated cell death types.
  • Lymphoproliferative disorders exhibit redox imbalance and altered iron metabolism, creating ferroptosis vulnerability.
  • Key factors like SLC7A11, lipid metabolism, and iron homeostasis regulate ferroptosis sensitivity in these cancers.

Purpose of the Study:

  • To review ferroptosis mechanisms in lymphoproliferative disorders.
  • To highlight ferroptosis interplay with cellular and metabolic pathways.
  • To discuss therapeutic strategies for inducing ferroptosis in cancer treatment.

Main Methods:

  • Literature review of ferroptosis mechanisms.
  • Analysis of cellular and metabolic pathway interactions.
  • Discussion of therapeutic targeting and clinical translation.

Main Results:

  • Ferroptosis is implicated in lymphoproliferative disorders due to specific metabolic and redox alterations.
  • Targeting ferroptosis pathways shows promise in overcoming treatment resistance.
  • Biomarker-driven strategies are essential for clinical translation.

Conclusions:

  • Ferroptosis is a critical vulnerability in lymphoproliferative malignancies.
  • Pharmacological induction of ferroptosis presents a novel therapeutic avenue.
  • Further research is needed for biomarker development and clinical application.